Axsome Thera
(AXSM)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -154,615 | -107,386 | -59,413 | -287,216 | -212,304 |
| Depreciation Amortization | 7,932 | 5,363 | 2,800 | 10,598 | 7,817 |
| Accounts receivable | -54,506 | -56,824 | -19,396 | -47,181 | -29,276 |
| Accounts payable and accrued liabilities | -17,770 | 19,631 | 13,662 | 31,318 | 23,574 |
| Other Working Capital | -15,697 | -24,480 | -10,149 | 33,478 | 21,101 |
| Other Operating Activity | 159,904 | 87,898 | 29,121 | 130,593 | 86,880 |
| Operating Cash Flow | $-74,752 | $-75,798 | $-43,375 | $-128,410 | $-102,208 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -409 | -351 | -338 | -270 | -240 |
| Investing Cash Flow | $-409 | $-351 | $-338 | $-270 | $-240 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 260,000 | 190,000 | N/A | N/A | N/A |
| Debt Repayment | -263,571 | -192,907 | -401 | -990 | -660 |
| Common Stock Issued | 106,449 | 80,979 | 36,685 | 71,464 | 53,897 |
| Other Financing Activity | -17,798 | -14,260 | -7,014 | -12,634 | -9,641 |
| Financing Cash Flow | $85,080 | $63,812 | $29,270 | $57,840 | $43,596 |
| Beginning Cash Position | 315,353 | 315,353 | 315,353 | 386,193 | 386,193 |
| End Cash Position | 325,272 | 303,016 | 300,910 | 315,353 | 327,341 |
| Net Cash Flow | $9,919 | $-12,337 | $-14,443 | $-70,840 | $-58,852 |
| Free Cash Flow | |||||
| Operating Cash Flow | -74,752 | -75,798 | -43,375 | -128,410 | -102,208 |
| Capital Expenditure | -409 | -351 | -338 | -270 | -240 |
| Free Cash Flow | -75,161 | -76,149 | -43,713 | -128,680 | -102,448 |